| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |